Types of Cancer

Types of Cancer

  • Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian
  • Hematologic Malignancies: Leukemia, Lymphoma, Multiple Myeloma.
  • Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers.
  • Gender-Specific Cancers: Gynecologic cancers, Prostate cancer.
  • Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers.

 

Cancer is not a single disease but a collection of over 100 different types, each with its unique characteristics, origins, and treatment approaches. The most prevalent types include carcinomas, which originate in the epithelial cells that line organs and tissues. These include breast cancer, lung cancer, and colorectal cancer, known for their varying degrees of aggressiveness and treatment options. Another significant category is sarcomas, which arise from connective tissues such as bones, muscles, and fat. These tumors are less common but can be particularly aggressive and include types like osteosarcoma and liposarcoma. Leukemias, on the other hand, are cancers of the blood-forming tissues, primarily affecting the bone marrow and leading to an overproduction of abnormal white blood cells. This category includes acute lymphoblastic leukemia and chronic myeloid leukemia. Lymphomas are cancers that originate in the lymphatic system, with two main types: Hodgkin lymphoma and non-Hodgkin lymphoma. Both types can affect lymph nodes and other lymphatic tissues, and their treatment may involve chemotherapy, radiation, or stem cell transplants. Melanomas, known for their origins in pigment-producing cells, are the most serious form of skin cancer due to their tendency to spread rapidly.

 

Additionally, cancers can also develop in the central nervous system, affecting the brain and spinal cord, with gliomas and meningiomas being common types. Gastrointestinal cancers, such as pancreatic, liver, and esophageal cancers, present unique challenges due to their late-stage diagnosis. Understanding the diverse types of cancer is crucial for developing targeted treatment strategies and improving patient outcomes. With ongoing research and advancements in personalized medicine, the approach to cancer treatment continues to evolve, offering hope for better management of these complex diseases.

Committee Members

Professor
Stefan Gluck

Sylvester Comprehensive Cancer Center, United States

Professor Emeritus
Rajvir Dahiya

University of California San Francisco School of Medicine, United States

Dean
Yan-Shen Shan

National Cheng Kung University Hospital, Taiwan

Principal Investigator
Henrique Manuel dos Santos Faneca

University of Coimbra (CNC-UC), Portugal

CANCER 2025 Speakers

Professor
Stefan Gluck

Sylvester Comprehensive Cancer Center, United States

Copyright 2024 Mathews International LLC All Rights Reserved

Watsapp
Top